Aurinia Pharmaceuticals Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Aurinia Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$15.1M, a 1018% decline year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$5.13M, a 311% decline from 2022.
  • Aurinia Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.43M, a 98.9% decline from 2021.
  • Aurinia Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $221M, a 13.8% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.13M -$7.56M -311% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $2.43M -$219M -98.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $221M +$26.7M +13.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $194M -$49.5M -20.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $244M +$240M +5975% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $4.01M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.